BioPharma Dive 18. Dez. 2025 Lilly obesity pill, headed for quick FDA review, hits mark in ‘maintenance’ trial
BioPharma Dive 18. Dez. 2025 Insmed’s ‘win streak’ ends as top drug fails study in chronic nasal condition
BioPharma Dive 18. Dez. 2025 Orum, a biotech marrying ADCs with protein degraders, captures $100M in funding
BioPharma Dive 17. Dez. 2025 Peanut allergy patch succeeds in late-stage study 5 years after FDA rejection
BioPharma Dive 17. Dez. 2025 Addition emerges with $100M to make gene therapies for chronic and rare diseases
BioPharma Dive 16. Dez. 2025 Nektar sees silver lining as autoimmune drug ‘narrowly’ misses in alopecia study